ELV
Elevance Health Inc.
$393.30
+$11.55(+3.03%)
80
Overall
100
Value
91
Tech
50
Quality
Market Cap
$80.15B
Volume
2.38M
52W Range
$273.71 - $424.24
Target Price
$384.70
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $84.9B | $90.0B | $92.1B | $104.2B | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B | $199.1B | ||
| Total Revenue | $84.9B | $90.0B | $92.1B | $104.2B | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B | $199.1B | ||
| OPERATING EXPENSES | ||||||||||||
| Selling, General & Administrative | $-12.6B | $12.7B | $14.0B | $13.4B | $17.4B | $15.9B | $17.7B | $20.1B | $20.0B | $21.0B | ||
| Selling & Marketing Expenses | $-1.4B | $-1.4B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $11.2B | $-11.3B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Salaries & Wages | -- | -- | -- | -- | $283.0M | $255.0M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-192.0M | $-169.0M | $-358.0M | $-338.0M | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | -- | -- | -- | -- | $638.0M | $668.0M | -- | -- | $1.2B | -- | ||
| Amortization | $-192.0M | $169.0M | $358.0M | $338.0M | $361.0M | $441.0M | $767.0M | $885.0M | $580.0M | $628.0M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | -- | -- | -- | -- | $-4.3B | $-5.0B | $-6.8B | $-18.9B | $-21.7B | $-24.2B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Other Income/Expense | $-35.1M | $-33.1M | -- | $-2.8B | $-10.4B | $-2.0M | $15.0B | $19.5B | $-201.0M | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restruct | -- | -- | -- | -- | -- | -- | -- | -- | -- | $1.4B | ||
| Special Income Charges | -- | $282.0M | $11.0M | $2.0M | $36.0M | $99.0M | $35.0M | $446.0M | $72.0M | $1.4B | ||
| Impairment of Capital Assets | -- | -- | -- | -- | $198.0M | $73.0M | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| Pre-Tax Income | $4.6B | $4.0B | $5.1B | $6.0B | $6.2B | $7.9B | $7.6B | $7.7B | $7.9B | $6.7B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-2.1B | $121.0M | $1.3B | $1.2B | $1.7B | $1.8B | $1.7B | $1.7B | $1.9B | $1.0B | ||
| NET INCOME | ||||||||||||
| Net Income | $2.5B | $3.8B | $3.8B | $4.8B | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | $5.7B | ||
| Net Income (Continuing Operations) | $2.5B | $3.8B | $3.8B | $4.8B | $4.6B | $6.1B | $5.9B | $6.0B | $6.0B | $5.7B | ||
| Net Income (Discontinued Operations) | $2.5B | $3.8B | $3.8B | $4.8B | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | $5.7B | ||
| Net Income (Common Stockholders) | $2.5B | $3.8B | $3.8B | $4.8B | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | $5.7B | ||
| Normalized Income | $3.1B | $2.6B | $4.0B | $4.7B | -- | -- | -- | -- | -- | $8.0B | ||
| TOTALS | ||||||||||||
| Total Expenses | $-80.3B | $-86.1B | $-87.0B | $-98.2B | $-115.6B | $-130.7B | $-149.0B | $-163.6B | $-169.1B | $-192.4B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $262.9M | $261.5M | $258.1M | $255.5M | $250.8M | $243.8M | $240.0M | $235.9M | $231.7M | $224.0M | ||
| Average Shares Outstanding (Diluted) | $268.1M | $267.8M | $264.2M | $260.3M | $254.3M | $246.8M | $242.8M | $237.4M | $232.9M | $224.6M | ||
| Shares Outstanding | $264.4M | $255.7M | $257.0M | $252.3M | $244.9M | $241.3M | $237.5M | $232.7M | $227.4M | $220.7M | ||
| Basic EPS | $9.39 | $14.7 | $14.53 | $18.81 | $18.23 | $25.04 | $25.1 | $25.38 | $25.81 | $25.28 | ||
| Basic EPS (Continuing Operations) | $9.39 | $14.7 | $14.53 | $18.81 | $18.23 | $25.04 | $25.1 | $25.38 | $25.81 | $25.28 | ||
| Diluted EPS | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.73 | $24.81 | $25.22 | $25.68 | $25.21 | ||
| Diluted EPS (Continuing Operations) | $9.21 | $14.35 | $14.19 | $18.47 | $17.98 | $24.73 | $24.81 | $25.22 | $25.68 | $25.21 | ||
| Dividend Per Share | $2.6 | $2.8 | $3 | $3.2 | $3.8 | $4.52 | $5.12 | $5.92 | -- | -- | ||
| OTHER METRICS | ||||||||||||
| Ceded Premiums | $80.0M | $44.0M | $51.0M | $45.0M | $79.0M | $74.0M | $64.0M | $61.0M | $66.0M | $114.0M | ||
| Fees And Commissions | $5.3B | $5.4B | $5.9B | $6.2B | -- | -- | -- | -- | -- | -- | ||
| Gross Premiums Written | $78.4B | $84.2B | $85.1B | $94.8B | $104.1B | $117.4B | $133.2B | $142.9B | $144.2B | $164.6B | ||
| Increase Decrease In Net Unearned Premium Reserves | $523.0M | -- | $373.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | -- | -- | -- | -- | $6.2B | $9.0M | $6.0M | $-4.0M | $9.0M | $1.0M | ||
| Net Investment Income | $664.0M | $834.0M | $970.0M | $1.0B | $841.0M | $1.4B | $1.5B | $1.8B | $2.1B | $2.2B | ||
| Net Premiums Written | $-78.9B | $-83.8B | $-85.2B | $-97.0B | $-104.1B | $-117.4B | $-133.2B | $-142.9B | $-144.2B | $-164.6B | ||
| Net Realized Gain Loss On Investments | $220.1M | $-282.0M | $-11.0M | $-2.0M | $-36.0M | $-21.0M | -- | -- | -- | -- | ||
| Other Gand A | $11.2B | $-11.3B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Total Premiums Earned | $78.9B | $83.6B | $85.4B | $94.2B | $104.1B | $117.4B | $133.2B | $142.9B | $144.2B | $164.6B | ||
| Intexp | $723.0M | $739.0M | $753.0M | $746.0M | $784.0M | $798.0M | $851.0M | $1.0B | -- | -- | ||
| Othspecchg | -- | $-282.0M | $-11.0M | $-2.0M | $29.0M | $26.0M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELV | $393.30 | +3.0% | 2.38M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |